The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Biogen Idec.
Robert
R
Fox
D000284:Administration, Oral; D017326:Clinical Trials, Phase III as Topic; D000069462:Dimethyl Fumarate; D005650:Fumarates / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000188:drug therapy*
D005650:Fumarates; D007166:Immunosuppressive Agents; D000069462:Dimethyl Fumarate